DNLI News
Archived Headlines
- Denali Therapeutics prices IPO at $18 midpoint making it the largest biotech IPO of the year 12/07/17
- Denali Therapeutics increases deal size of tonight's IPO to $250 million 12/07/17
- US IPO Week Ahead: Two big biotechs lead 6-IPO week 12/01/17
- Denali Therapeutics sets terms for $150 million IPO 11/27/17
- US IPO Week Ahead: IPOs ready to launch in final stretch of 2017 11/24/17
See more
No trial, no problem: Biggest week for preclinical biotech IPOs ever
Three large preclinical biotech IPOs are slated to begin trading on Friday, the most ever in a single week. Vaxcyte (PCVX) is developing next-generation pneumonia vaccines, a $7 billion market, and expects to begin clinical trials for its...read more
Pushing preclinical: Wave of early-stage biotech IPOs tests investor risk appetite
Biotechs are among the most risky of IPOs due to the binary nature of the success… or failure of their drugs. In the past, most biotechs delayed public offerings until they at least showed clinical evidence of their safety or efficacy. But in 2018,...read more
US IPO Week Ahead: 2018 IPO market kicks off with a quiet week
There are no deals set to price in the first week of the new year; however, filing activity will continue from companies targeting 1Q18 IPOs. The IPO market rounded out 2017 at an even 160 IPOs, raising $35.5 billion in total proceeds, nearly double that of 2016...read more
US IPO Weekly Recap: Year's largest biotech headlines 6-IPO week
Led by the largest biotech IPO since June 2015, six companies raised $827 million this past week. Biotech Denali Therapeutics raised $250 million, making it the largest biotech IPO of year by both deal size and market cap. The week also included pricings...read more